{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:10:46Z","timestamp":1790097046596,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejso.2026.112130","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:16:05Z","timestamp":1789830965000},"page":"112130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular surgery in colorectal cancer: Integrating genomics into operative decision-making"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5522-8844","authenticated-orcid":false,"given":"Jos\u00e9","family":"Perea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1493-1768","authenticated-orcid":false,"given":"Antonino","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2026.112130_bib1","volume":"1","author":"Dienstmann","year":"2015","journal-title":"Colorect cancer Nat Rev Dis Prim"},{"issue":"1","key":"10.1016\/j.ejso.2026.112130_bib2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41591-022-02115-4","article-title":"Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer","volume":"29","author":"Kotani","year":"2023","journal-title":"Nat Med"},{"issue":"25","key":"10.1016\/j.ejso.2026.112130_bib3","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMoa2201445","article-title":"PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer","volume":"386","author":"Cercek","year":"2022","journal-title":"N Engl J Med"},{"issue":"10139","key":"10.1016\/j.ejso.2026.112130_bib4","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/S0140-6736(18)31078-X","article-title":"Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International watch & wait database (IWWD): an international multicentre registry study","volume":"391","author":"van der Valk","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ejso.2026.112130_bib5","article-title":"Metachronous colorectal cancer risks after extended or segmental resection in MLH1, MSH2, and MSH6 Lynch syndrome: multicentre study from the prospective Lynch syndrome database","volume":"112","author":"Zalevskaja","year":"2025","journal-title":"Br J Surg"},{"issue":"3","key":"10.1016\/j.ejso.2026.112130_bib6","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.cgh.2006.12.014","article-title":"Genotype-phenotype correlations as a guide in the management of familial adenomatous polyposis","volume":"5","author":"Nieuwenhuis","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"21","key":"10.1016\/j.ejso.2026.112130_bib7","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1056\/NEJMoa2400634","article-title":"Neoadjuvant immunotherapy in locally advanced mismatch repair-deficient colon cancer","volume":"390","author":"Chalabi","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejso.2026.112130_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-024-03254-6","article-title":"ctDNA-based molecular residual disease and survival in resectable colorectal cancer","volume":"30","author":"Nakamura","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.ejso.2026.112130_bib9","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/S0140-6736(18)31078-X","article-title":"Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International watch & wait database (IWWD): an international multicentre registry study","volume":"391","author":"van der Valk","year":"2018","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ejso.2026.112130_bib10","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/DCR.0b013e3181a0d33b","article-title":"Genotype predicting phenotype in familial adenomatous polyposis: a practical application to the choice of surgery","volume":"52","author":"Nieuwenhuis","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ejso.2026.112130_bib11","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1056\/NEJMoa2200075","article-title":"Circulating tumor DNA analysis guiding adjuvant therapy in stage II Colon cancer","volume":"386","author":"Tie","year":"2022","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ejso.2026.112130_bib12","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/s41591-025-03579-w","article-title":"Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial","volume":"31","author":"Tie","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.ejso.2026.112130_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1470-2045(20)30557-X","article-title":"Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International watch & wait database: a retrospective, international, multicentre registry study","volume":"22","author":"Fernandez","year":"2021","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2026.112130_bib14","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S2468-1253(24)00158-4","article-title":"Watch and wait for rectal cancer: towards data-informed surveillance","volume":"9","author":"Dossa","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.ejso.2026.112130_bib15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41698-025-01208-w","article-title":"Ultrasensitive ctDNA monitoring for organ preservation in patients with locally advanced rectal cancer","volume":"10","author":"Manca","year":"2025","journal-title":"npj Precis Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.112130_bib16","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1200\/JCO.23.00586","article-title":"International validation of the immunoscore biopsy in patients with rectal cancer managed by a watch-and-wait strategy","volume":"42","author":"El Sissy","year":"2024","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2026.112130_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyaf354","article-title":"The utility of ctDNA in rectal cancer","volume":"30","author":"Brar","year":"2025","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.ejso.2026.112130_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/wjs.12443","article-title":"Segmental versus extended colectomy for colorectal cancer in patients with Lynch syndrome: a systematic review and meta-analysis","volume":"49","author":"Pasqualotto","year":"2025","journal-title":"World J Surg"},{"issue":"6","key":"10.1016\/j.ejso.2026.112130_bib19","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/codi.13679","article-title":"Risk of metachronous colorectal cancer following colectomy in Lynch syndrome: a systematic review and meta-analysis","volume":"19","author":"Anele","year":"2017","journal-title":"Colorectal Dis"},{"issue":"5","key":"10.1016\/j.ejso.2026.112130_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/bjsopen\/zrae092","article-title":"Risk of metachronous neoplasia in early-onset colorectal cancer: meta-analysis","volume":"8","author":"Pellino","year":"2024","journal-title":"BJS Open"},{"issue":"3","key":"10.1016\/j.ejso.2026.112130_bib21","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/gutjnl-2019-319915","article-title":"Guidelines for the management of hereditary colorectal cancer from the British society of gastroenterology (BSG)\/association of coloproctology of Great Britain and Ireland (ACPGBI)\/united kingdom cancer genetics group (UKCGG)","volume":"69","author":"Monahan","year":"2020","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.ejso.2026.112130_bib22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s00384-026-05145-3","article-title":"Early-onset colorectal cancer: a comprehensive reframing the field with new hypotheses and research priorities","volume":"41","author":"Catani","year":"2026","journal-title":"Int J Colorectal Dis"},{"issue":"8","key":"10.1016\/j.ejso.2026.112130_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2025.110019","article-title":"Network meta-analysis of RTCs for efficacy of neoadjuvant treatment in rectal cancer","volume":"51","author":"Horesh","year":"2025","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2026.112130_bib24","first-page":"640","article-title":"NICHE-2 validates the efficacy of neoadjuvant ICIs in dMMR colon cancer","volume":"21","author":"Killock","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2026.112130_bib25","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S2468-1253(24)00191-2","article-title":"Optimising local treatment decisions for rectal cancer","volume":"9","author":"Jethwa","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"346","key":"10.1016\/j.ejso.2026.112130_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf6219","article-title":"Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer","volume":"8","author":"Tie","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ejso.2026.112130_bib27","doi-asserted-by":"crossref","first-page":"112","DOI":"10.21037\/dmr.2020.04.02","article-title":"Assaying circulating-tumor DNA to predict recurrence of localized Colon cancer","volume":"3","author":"Carethers","year":"2020","journal-title":"Dig Med Res"},{"issue":"12","key":"10.1016\/j.ejso.2026.112130_bib28","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1007\/s11912-025-01725-8","article-title":"From early detection to advanced therapies: how circulating tumor DNA is transforming the care of colorectal cancer","volume":"27","author":"Yee","year":"2025","journal-title":"Curr Oncol Rep"},{"issue":"8","key":"10.1016\/j.ejso.2026.112130_bib29","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1158\/0008-5472.CAN-24-2464","article-title":"An immune subtype classification system enables the development of strategies to predict and enhance immunotherapy responses in colorectal cancer","volume":"85","author":"Li","year":"2025","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.ejso.2026.112130_bib30","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41571-023-00766-x","article-title":"Gut microbiota in colorectal cancer development and therapy","volume":"20","author":"Wong","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2026.112130_bib31","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41579-023-00973-4","article-title":"The microbial landscape of colorectal cancer","volume":"22","author":"White","year":"2024","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.ejso.2026.112130_bib32","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1186\/s12885-021-08664-0","article-title":"The role of the bacterial microbiome in the treatment of cancer","volume":"21","author":"Yu","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2026.112130_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1110787","article-title":"The implication of gut microbiota in recovery from gastrointestinal surgery","volume":"13","author":"Zheng","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.ejso.2026.112130_bib34","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41698-024-00699-3","article-title":"Illuminating the future of precision cancer surgery with fluorescence imaging and artificial intelligence convergence","volume":"8","author":"Cheng","year":"2024","journal-title":"npj Precis Oncol"},{"key":"10.1016\/j.ejso.2026.112130_bib35","article-title":"Advancing AI for multi-omics and clinical data integration in basic and translational cancer research","volume":"21","author":"Liu","year":"2026","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.ejso.2026.112130_bib36","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1308\/rcsann.2024.0031","article-title":"Current and future genomic applications for surgeons","volume":"106","author":"Alkhatib","year":"2024","journal-title":"Ann R Coll Surg Engl"},{"issue":"11","key":"10.1016\/j.ejso.2026.112130_bib37","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.jtho.2025.07.009","article-title":"Molecular tumor boards: a consensus statement from the international association for the study of lung cancer","volume":"20","author":"Aldea","year":"2025","journal-title":"J Thorac Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2026.112130_bib38","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.annonc.2025.02.009","article-title":"ESMO precision oncology working group recommendations on the structure and quality indicators for molecular tumour boards in clinical practice","volume":"36","author":"Westphalen","year":"2025","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2026.112130_bib39","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.annonc.2024.06.018","article-title":"ESMO recommendations on clinical reporting of genomic test results for solid cancers","volume":"35","author":"van de Haar","year":"2024","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2026.112130_bib40","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1200\/JCO.22.00796","article-title":"We can, but should we? Ethical considerations in reporting germline findings from paired tumor-normal genomic testing in patients with advanced cancer","volume":"41","author":"Hunter","year":"2023","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2026.112130_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2024.101270","article-title":"Ethical, legal, and social issues related to genetics and genomics in cancer: a scoping review and narrative synthesis","volume":"26","author":"Smit","year":"2024","journal-title":"Genet Med"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326007493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326007493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:49:28Z","timestamp":1790095768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326007493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0748798326007493"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.112130","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular surgery in colorectal cancer: Integrating genomics into operative decision-making","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.112130","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112130"}}